Literature DB >> 6753738

Effect of rifampin on ampicillin killing of group B streptococci.

S M Smith, R H Eng, S Landesman.   

Abstract

The activity of rifampin against group B streptococci as a single agent and in combination with ampicillin was examined. The minimum concentration of rifampin required to inhibit 90% of the isolates of group B streptococci (18 of 20 isolates) was 0.6 microgram/ml. The checkerboard double-dilution studies of these two antibiotics and the time-killing studies both indicate that rifampin inhibits the bactericidal activity of ampicillin for group B streptococci.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6753738      PMCID： PMC183778          DOI： 10.1128/AAC.22.3.522

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

Review 1.  Group B streptococcus (S. agalactiae) bacteremia in adults: analysis of 32 cases and review of the literature.

Authors:  P I Lerner; K V Gopalakrishna; E Wolinsky; M C McHenry; J S Tan; M Rosenthal
Journal:  Medicine (Baltimore)       Date:  1977-11       Impact factor: 1.889

2.  Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies.

Authors:  G L Mandell; T K Vest
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

3.  Aminoglycoside therapy of gram-negative bacillary meningitis.

Authors:  A B Kaiser; Z A McGee
Journal:  N Engl J Med       Date:  1975-12-11       Impact factor: 91.245

Review 4.  Group B streptococci in human disease.

Authors:  M J Patterson; A El Batool Hafeez
Journal:  Bacteriol Rev       Date:  1976-09

5.  Serious infections in adults due to group B streptococci. Clinical and serotypic characterization.

Authors:  A S Bayer; A W Chow; B F Anthony; L B Guze
Journal:  Am J Med       Date:  1976-10       Impact factor: 4.965

6.  Recurrence of group B streptococcal infection.

Authors:  D D Broughton; W G Mitchell; M Grossman; W K Hadley; M S Cohen
Journal:  J Pediatr       Date:  1976-08       Impact factor: 4.406

7.  Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy.

Authors:  H W Murray; F M Wigley; J J Mann; R R Arthur
Journal:  Arch Intern Med       Date:  1976-04

8.  In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus.

Authors:  C U Tuazon; M Y Lin; J N Sheagren
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

9.  Importance of medium in demonstrating penicillin tolerance by group B streptococci.

Authors:  K S Kim; R N Yoshimori; D T Imagawa; B F Anthony
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

10.  The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis.

Authors:  R M Massanari; S T Donta
Journal:  Chest       Date:  1978-03       Impact factor: 9.410
View more
  1 in total

1.  Streptococcus agalactiae (group B) endocarditis--a description of twelve cases and review of the literature.

Authors:  B E Scully; D Spriggs; H C Neu
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.